S&P 5007,659▼ 1.09%Nasdaq26,140▼ 2.15%Dow Jones52,002▼ 0.34%Nasdaq 10029,188▼ 2.50%VIX19.99▲ 21.45%US Dollar101.84▼ 0.21%Gold (GLD)382.01▼ 0.18%Oil (USO)161.76▲ 2.83%
Home › ALL › Research report
← ALL page
XStocksXray
Research report · 16 October 2026

Allstate Corp (ALL)

Financials · Property & Casualty Insurance · US stock · price as of 16 Oct 2026

Key indicators

Price$247.88
52-week range$184.51 – $276.07
Market cap$64.2B
P/E (trailing)5.0×
Dividend yield1.7%
Revenue (last 12 months)$70.1B
Revenue growth (3y a year)9.6%
Price / book1.9×
Return on equity39.1%

Fair value

Blended fair value$256.64 book-value models
Versus priceFair+4% to fair value
Excess-return model (banks, insurers)$198.07
Price / book vs return on equity$344.50
Model uncertaintyHigh

X-Ray Score

55/ 100 · Low confidence · ahead of 70% of sector peers
Valuation78
Growth62
Profitability27
Financial health55
Dividends60

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

83.60134184234285Fair value $2572021-102023-012024-042025-072026-10

Executive summary

Allstate is an insurance group that sells property and casualty products, mainly auto and homeowners insurance, to households in the United States. It also offers other protection plans and products. The company earns money by collecting premiums and investing them, and it profits when premiums and investment income exceed claims and expenses. Catastrophe losses, such as storms and wildfires, can cause large swings in its results.

Over the latest twelve months the company reported revenue of $70.1 billion, and annual revenue rose by 9.6% on average across three years. A dividend is paid, with a yield of 1.7%.

StocksXray gives Allstate Corp an X-Ray Score of 55 out of 100 (low confidence), ahead of 70% of the S&P 500 stocks in its sector. Its strongest lens is valuation (78) and its weakest is profitability (27).

Our fair value blend is $256.64. At $247.88 the stock trades 3% below that blend, so the label is "Fair" with high model uncertainty. Fair value is a range, not a price target.

stocksxray.com · page 1
XStocksXray
Allstate Corp (ALL)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2021FY2022FY2023FY2024FY2025Now
Price$105.26$124.61$132.54$186.37$205.16$247.88
Market cap$31.5B$33.8B$34.8B$49.9B$54.8B$64.2B
P/E21.0×––11.0×5.4×5.0×
Price / book1.3×1.9×2.0×2.3×1.8×1.9×
Dividend yield3.08%2.73%2.69%1.97%1.95%1.71%

Fundamentals checklist ● 1 Good · ● 3 Average · ● 0 Bad · each check graded against the sector

Risk models

Piotroski F-Score7 of 9Average

Growth

Revenue growth (3y)9.6%Average
Growth consistency100%Good

Valuation

Fair value vs price1.0×Average
stocksxray.com · page 2
XStocksXray
Allstate Corp (ALL)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY21FY22FY23FY24FY25LTM
Revenue50,60151,41157,09464,10667,68570,137
Net income1,485-1,416-3164,55010,16513,189
Diluted EPS ($)5.01-5.14-1.2016.9938.0650.00
Net margin2.9%−2.8%−0.6%7.1%15.0%18.8%
Balance sheetFY21FY22FY23FY24FY25LTM
Total assets99,44097,989103,362111,617119,758124,756
Cash763736722704678840
Total debt7,9767,9647,9428,0857,4907,492
Equity24,94417,48817,77021,44230,61033,698
Dividend per share ($)3.243.403.563.684.004.16

Revenue and net income US$ billions: navy revenue, teal net income

FY21FY22FY23FY24FY25

Margins blue gross, teal operating, brown net

-3%5%12%19%FY21FY22FY23FY24FY25

Latest quarters

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue ($M)16,45216,63317,25517,34516,94118,596
Growth vs a year earlier+7.8%+5.8%+3.8%+5.1%+3.0%+11.8%
Net income ($M)5952,1093,7463,7152,4573,271
Diluted EPS ($)2.117.7613.9514.379.2512.51
stocksxray.com · page 3
XStocksXray
Allstate Corp (ALL)

Peers in Property & Casualty Insurance

CompanyX-Ray
ALL · Allstate Corp55
ACGL · Arch Capital Group Ltd.67
HIG · Hartford Insurance Group,...66
PGR · Progressive Corp65
CINF · Cincinnati Financial Corp64

Market Compass outlook for Financials: Favourable (72/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week+8.0%
1 month−1.7%
3 months−1.9%
6 months+15.8%
1 year+26.1%
3 years+129.6%
5 years+119.9%

Technical summary

DailyBullish11 bullish · 1 neutral · 4 bearish
WeeklyStrongly bullish10 bullish · 1 neutral · 1 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish
50-day / 200-day average$246.58 / $224.43
52-week low / high$184.51 / $276.07
Classic pivot, support and resistanceS2 238.49 · S1 243.19 · P – · R1 250.49 · R2 253.09

Recent dividends

Ex-dividend dateAmount per share
31 Aug 2026$1.0800
1 Jun 2026$1.0800
2 Mar 2026$1.0800
1 Dec 2025$1.0000
29 Aug 2025$1.0000
9 Jun 2025$1.0000
stocksxray.com · page 4
XStocksXray
Allstate Corp (ALL)

Strengths

  • Piotroski F-Score of 7 out of 9: most of the nine accounting health tests pass.
  • Has raised its dividend for 7 years in a row.

Risks and weak spots

No check is weak against its sector.

Latest SEC filings

DateFormItems
15 Oct 20268-K7.01,9.01
17 Sep 20268-K7.01,9.01
20 Aug 20268-K7.01,9.01
5 Aug 202610-Q
5 Aug 20268-K2.02,9.01
16 Jul 20268-K7.01,9.01
14 Jul 20268-K5.02,7.01,9.01
18 Jun 20268-K7.01,9.01

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 19 Oct 2026